Full text is available at the source.
Neuroprotection of chicoric acid in a mouse model of Parkinson's disease involves gut microbiota and TLR4 signaling pathway
Chicoric acid may protect brain cells in Parkinson's mice through gut bacteria and immune signaling
AI simplified
Abstract
Oral pretreatments of chicoric acid significantly prevented MPTP-induced motor dysfunctions and death of dopaminergic neurons.
- Chicoric acid is associated with the inhibition of glial hyperactivation and an increase in neurotrophins in the striatum.
- CA significantly reduced microbial dysbiosis induced by MPTP and partially restored gut microbiota composition.
- CA promoted the integrity of the colonic epithelium and normalized short-chain fatty acid production.
- Proinflammatory cytokines TNF-α and IL-1β were reduced in the serum, striatum, and colon with CA treatment.
- Inhibition of the TLR4/MyD88/NF-ĪŗB signaling pathway may underlie the anti-inflammatory effects of CA.
AI simplified